Turning Sour On Apple… And Single Stock Volatility On The Rise 1/8/26
CNBC's "Fast Money"
00:00
Merck Acquisitions and Biotech M&A Outlook
Panel covers Merck's Sedera deal, potential Revolution Medicines interest, and broad patent-cliff driven takeover activity.
Play episode from 40:52
Transcript
